NCT03628677 2025-02-04A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced MalignanciesArcus Biosciences, Inc.Phase 1 Completed75 enrolled
NCT04087018 2024-09-19Study to Evaluate Safety and Clinical Activity of AB122 in Biomarker Selected Participants With Advanced Solid TumorsArcus Biosciences, Inc.Phase 1 Completed18 enrolled